NeuroSense Says Phase 2b ALS Trial Meets Primary And Secondary Endpoints

RTTNews | Před 664 dny
NeuroSense Says Phase 2b ALS Trial Meets Primary And Secondary Endpoints

(RTTNews) - NeuroSense Therapeutics Ltd. (NRSN) announced Tuesday that it met its primary safety and tolerability endpoints and achieved secondary clinical efficacy endpoints in the top-line results of its 6-month, randomized, placebo-controlled, double-blind segment the Company's Phase 2b amyotrophic lateral sclerosis (ALS) trial of PrimeC (PARADIGM).

The trial's secondary clinical efficacy outcome measure endpoints included Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) and Slow Vital Capacity (SVC), a measure of respiratory function.

NeuroSense expects to report an additional primary biomarker endpoint of the assessment of ALS hallmarks, TDP-43 and Prostagladin2, to evaluate PrimeC's biological activity, in the first half of 2024 following the completion of the analysis of participants' plasma.

The PARADIGM (NCT05357950) trial is a prospective, multinational, randomized, double-blind, placebo-controlled Phase 2b clinical trial of PrimeC in ALS.

NeuroSense expects to report results from a strategic collaboration with Biogen in January 2024, evaluating the impact of PrimeC on neurofilament levels in participants enrolled in PARADIGM.

Upon receipt of results, Biogen has the right of first refusal to co-develop/commercialize PrimeC for the treatment of ALS for a limited time following the results.

read more
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

The Switzerland market closed on a firm note on Monday, outperforming most of the major markets in Europe, with several stocks turning in a fine performance thanks to sustained buying support.
RTTNews | Před 3 h 23 min
India Industrial Production Growth Slows In August

India Industrial Production Growth Slows In August

India's industrial output growth eased slightly in August after a spike in July, and growth was led by a strong performance in the mining sector and production of infrastructure goods, preliminary data from the statistical ministry showed on Monday.
RTTNews | Před 6 h 56 min
U.S. Pending Home Sales Surge Much More Than Expected In August

U.S. Pending Home Sales Surge Much More Than Expected In August

Pending home sales in the U.S. soared by far more than expected in the month of August, the National Association of Realtors revealed in a report released on Monday. NAR said its pending home sales index spiked by 4.0 percent to 74.7 in August after falling by 0.3 percent to a revised 71.8 in July. Economists had expected pending home sales to rise by 0.3 percent.
RTTNews | Před 7 h 27 min